secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bausch Health Companies Inc. (BHC)
CIK:        0000885590
Form:       8-K
Filed at:   2021-10-21T23:59:59+00:00
Accession:  0000885590-21-000050
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bausch Health names Tom Vadaketh as future CFO, Sam Eldessouky to move to Bausch + Lomb
--------------------------------------------------------------------------------

- Sam Eldessouky will become CFO of Bausch + Lomb upon closing of its IPO.
- Tom Vadaketh joins from eResearch Technology and will succeed Eldessouky as Bausch Health CFO at IPO close.
- Vadaketh receives annual base salary of $600,000, target bonus of 60% of base, sign-on cash of $500,000, and equity grant of $3 million.
- Employment agreement has initial three-year term with automatic one-year renewals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/885590/000088559021000050/0000885590-21-000050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/885590/000088559021000050/bhc-20211020.htm
  HTML page:      https://secwatch.observer/filing/0000885590-21-000050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer